SWTX: SpringWorks Therapeutics, Inc. Common Stock Company Profile & Statistics

About

SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.

Info & Links

CEO

Saqib Islam

Headquarters

100 WASHINGTON BOULEVARD
STAMFORD, CT 06902, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

368

SpringWorks Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

2.84B

Enterprise Value

2.77B

Enterprise Value/EBITDA(ttm)

-10.10

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

23.27

Price to Book(mrq)

8.36

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

93.59%

Operating Margin(ttm)

-134.73%

Profit Margin(ttm)

-179.25%

Return on Equity(ttm)

-46.74%

Return on Invested Capital(ttm)

-48.69%

Return on Assets(ttm)

-41.12%

Income Statement

Revenue(ttm)

191.59M

Revenue Per Share(ttm)

2.56

Gross Profit(ttm)

179.04M

EBITDA(ttm)³

-274.66M

Net Income Available to Common(ttm)

-258.13M

Diluted EPS(ttm)

-3.48

Share Statistics

Beta (5Y Monthly)

0.81

52-Week Change

-14.01%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

74.94M

Dividend Yield

0.00%

Float⁴

68.72M

% Held by Insiders

7.61%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

307.99M

Total Cash Per Share(mrq)

4.11

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.81%

Quick Ratio(mrq)

6.02%

Book Value Per Share(mrq)

6.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.37

Free Cash Flow(ytd)

-180.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SWTX

SpringWorks Therapeutics, Inc. Common Stock

SpringWorks Therapeutics, Inc. Common Stock Profile